Meta-analyses argue that BRAF p.V600E predicts lymph node metastasis, but whether BRAF p.V600E is associated with PTC subtype, tumor size, loco-regional recurrence, and distant metastasis is not clear [6–11]. This evidence concerns the gene BRAF and metastatic malignant neoplasm in the lymph nodes.